Details for: CL0001029

Cell ID: CL0001029

Cell Name: common dendritic progenitor

Description: Surface markers are for mouse cells. Originally described in the dendritic cell ontology (DC_CL:0000041) CDP are reportedly CD2-negative, CD3-negative, CD4-negative, CD5-negative, CD8a-negative, CD11c-positive, CD14-negative, CD19-negative, CD20-negative, CD56-negative, B220-negative, Ly6g-negative, MHCII-positive, and Ter119-negative. (PMID:19243617).

Synonyms: common dendritic precursor, CDP, pro-DCs

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for common dendritic progenitor within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for common dendritic progenitor. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for common dendritic progenitor. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for common dendritic progenitor. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  common dendritic progenitor (CL0001029)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [common dendritic progenitor](/details-cell/CL0001029) (CDP) is a hematopoietic precursor cell committed to the dendritic cell lineage. Based on gene significance analysis, the CDP identity is not defined by unique lineage-specific transcription factors but rather by a highly specific and robust expression of genes involved in core cellular processes. **Overall**, the top marker genes highlight an intense engagement in RNA processing (splicing and transport), transcriptional regulation, and high metabolic activity. This genetic signature suggests that the CDP exists in a state of heightened preparedness, equipped with the fundamental machinery required for rapid and complex differentiation into various [dendritic cell](/details-cell/CL0000451) subsets upon receiving appropriate signals. ## Key Characteristics and Function The functional identity of the [common dendritic progenitor](/details-cell/CL0001029) is underscored by several clusters of specifically expressed genes. * **RNA Processing and Post-Transcriptional Regulation:** A defining feature of CDPs is the prominent and specific expression of a large cohort of heterogeneous nuclear ribonucleoproteins (hnRNPs), including [HNRNPA2B1](/details-gene/3181), [HNRNPC](/details-gene/3192), [HNRNPA1](/details-gene/3178), [HNRNPA3](/details-gene/220988), [HNRNPDL](/details-gene/9987), and [HNRNPU](/details-gene/3192). These proteins are central to mRNA splicing, processing, and nuclear export. Their high specificity suggests that complex alternative splicing and post-transcriptional control are critical mechanisms for maintaining the progenitor state and directing subsequent lineage commitment. * **High Metabolic Activity:** The specific expression of multiple genes related to cellular respiration, such as the mitochondrially-encoded [ND4](/details-gene/4538) and [COX1](/details-gene/4512), as well as nuclear-encoded mitochondrial components like [COX4I1](/details-gene/1327) and [NDUFA4](/details-gene/4697), points towards a high reliance on oxidative phosphorylation. The high score for [GAPDH](/details-gene/2597) further supports a highly active metabolic profile. This robust bioenergetic capacity is likely essential to fuel the demanding processes of cell division and differentiation. * **Transcriptional and Chromatin Control:** CDPs exhibit specific expression of key regulators of chromatin architecture and transcription. The top marker, [HMGB1](/details-gene/3146), is a non-histone chromosomal protein that influences DNA structure and gene expression. Other significant genes include the general transcription factor [BTF3](/details-gene/689), the ribosome biogenesis factor [NPM1](/details-gene/4869), and the multifunctional DNA/RNA-binding protein [YBX1](/details-gene/4904). This profile indicates that the cell's fate is actively managed at the most fundamental levels of gene regulation. * **Lineage Purity:** The analysis of anti-markers confirms the cell's defined lineage. The low expression specificity for markers of mature B-cells like [CD72](/details-gene/971) and [CD22](/details-gene/933), or the key neutrophil enzyme [MPO](/details-gene/4353), effectively distinguishes CDPs from other hematopoietic lineages and reinforces their identity as committed dendritic cell precursors. ## Clinical Significance and Contextual Roles While this analysis provides a baseline profile, the specific gene signature of CDPs has potential clinical implications. The top marker, [HMGB1](/details-gene/3146), is a well-known damage-associated molecular pattern (DAMP) when released from cells, functioning as a potent pro-inflammatory cytokine. Its high intrinsic expression in CDPs suggests these progenitors may be uniquely positioned to sense and respond to tissue damage or stress within the bone marrow, potentially linking sterile inflammation directly to the replenishment of the dendritic cell pool. Furthermore, several top markers are implicated in cancer. [NPM1](/details-gene/4869) is one of the most frequently mutated genes in acute myeloid leukemia (AML), and its high specific expression in this progenitor cell could be relevant for understanding the cell-of-origin for certain hematopoietic malignancies. Similarly, [YBX1](/details-gene/4904) is known to be involved in oncogenesis through its roles in transcription and translation. The robust expression of fundamental cellular machinery could render these cells particularly sensitive to therapeutic agents that target RNA splicing or metabolism, suggesting potential avenues for intervention in diseases characterized by aberrant dendritic cell activity or number. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The high expression specificity of numerous hnRNP family members indicates that alternative mRNA splicing is a primary regulatory mechanism governing the fate of [common dendritic progenitor](/details-cell/CL0001029) cells. This complex RNA processing network may function as a central node, integrating external signals (e.g., from cytokines) to orchestrate differentiation into conventional versus plasmacytoid dendritic cell lineages. * **Surprising Findings:** It is notable that genes involved in the universal process of RNA splicing, such as [HNRNPA2B1](/details-gene/3181) and [HNRNPC](/details-gene/3192), demonstrate greater expression specificity for this cell type than many canonical lineage-defining transcription factors. This suggests that the unique identity of the CDP may be established not by the presence of a single master regulator, but by the fine-tuned regulation of its core processing machinery. * **Testable Questions:** Does the targeted inhibition or knockdown of a highly specific hnRNP, like [HNRNPA1](/details-gene/3178), in hematopoietic progenitors alter the balance of dendritic cell subset differentiation from CDPs *in vitro* following stimulation with Flt3L? 2. **Hypothesis:** The status of [HMGB1](/details-gene/3146) as the top specificity marker suggests that CDPs are not passive precursors but are intrinsically primed to act as sensors of cellular stress within the hematopoietic niche. Their high level of intracellular [HMGB1](/details-gene/3146) may serve as a ready reservoir that, upon release, can signal tissue damage and drive emergency dendritopoiesis to replenish the immune system's sentinel network. * **Surprising Findings:** While [HMGB1](/details-gene/3146) is extensively studied as an extracellular alarmin, its high expression *specificity* points to a uniquely critical *intracellular* function in CDPs, potentially related to maintaining a specific chromatin state or transcriptional program that defines the progenitor identity. * **Testable Questions:** Can inflammatory signals known to cause [HMGB1](/details-gene/3146) release, such as pyroptosis inducers, trigger the differentiation of CDPs? Furthermore, does the addition of extracellular recombinant [HMGB1](/details-gene/3146) to CDP cultures promote their proliferation or skew their differentiation towards a specific pro-inflammatory dendritic cell subtype?